Loading...
Portfolio Diversification
Range
Most Diversified
32 instruments
September 16, 2026
Least Diversified
0 instruments
February 1, 2022
Average
29.2 instruments
Most Consistent Holdings
Top 5
JNJ97.4%
MRK97.4%
PFE97.4%
AMGN97.4%
ABBV97.4%
Position Sizing
Analysis
Market Exposure
Analysis
Top Sectors
Top 5
Top Countries
Top 5
Holdings over time
(Since February 1, 2022)
| Instrument | Avg. Exposure | Current Exposure | Time Holding | Last Closed |
|---|---|---|---|---|
 Guardant Health (GH) | 4.01% | 5.84% | 96.98% | - |
 Bridgebio (BBIO) | 3.95% | 2.74% | 79.89% | - |
 Eli Lilly (LLY) | 3.69% | 3.4% | 97.4% | - |
 Gilead Sciences (GILD) | 3.27% | 3.42% | 97.4% | - |
| Merck (MRK) | 3.22% | 3.53% | 97.4% | - |
| Johnson & Johnson (JNJ) | 3.2% | 3.13% | 97.4% | - |
 Revolution Medicines (RVMD) | 3.17% | 7.07% | 80.01% | - |
| AbbVie (ABBV) | 3.08% | 3.18% | 97.4% | - |
| Amgen (AMGN) | 3.07% | 3.1% | 97.4% | - |
 Exact Sciences (EXAS) | 3.05% | 0% | 85.75% | 3/25/2026 |
 Regeneron (REGN) | 3.03% | 2.74% | 96.51% | - |
 Illumina (ILMN) | 2.97% | 4.53% | 96.98% | - |
 Bristol-Myers Squibb (BMY) | 2.91% | 2.6% | 97.04% | - |
| Pfizer (PFE) | 2.89% | 3.11% | 97.4% | - |
 Vertex (VRTX) | 2.88% | 0% | 80.66% | 12/29/2025 |
 Exelixis (EXEL) | 2.66% | 3.08% | 76.05% | - |
 Argenx (ARGX) | 2.51% | 2.52% | 79.66% | - |
 Syndax (SNDX) | 2.41% | 1.91% | 80.01% | - |
 ImmunoGen Inc (IMGN) | 2.36% | 0% | 40.51% | 2/14/2024 |
 CRISPR Therapeutics (CRSP) | 2.06% | 0% | 59.08% | 12/26/2024 |
 Arcellx (ACLX) | 1.83% | 0% | 49.79% | 4/30/2026 |
 Iovance (IOVA) | 1.82% | 2.43% | 65.23% | - |
 Blueprint Medicines (BPMC) | 1.8% | 0% | 54.05% | 7/23/2025 |
 AstraZeneca (AZN) | 1.77% | 2.06% | 59.37% | - |
 BeiGene (ONC) | 1.48% | 2.73% | 54.35% | - |
 TG Therapeutics (TGTX) | 1.37% | 0% | 39.03% | 12/29/2025 |
 Scholar Rock (SRRK) | 1.36% | 3.05% | 38.32% | - |
 Halozyme (HALO) | 1.26% | 4.13% | 37.91% | - |
 Mirati Therapeutics Inc (MRTX) | 1.2% | 0% | 39.68% | 1/31/2024 |
 Zai Lab (ZLAB) | 1.15% | 0% | 42.05% | 12/29/2025 |
 SpringWorks Therapeutics (SWTX) | 1.15% | 0% | 32.29% | 7/3/2025 |
 BD (BDX) | 1.13% | 0% | 42.7% | 12/29/2025 |
 Crinetics (CRNX) | 1.08% | 0% | 28.8% | 12/29/2025 |
 Celldex (CLDX) | 0.95% | 2.52% | 37.32% | - |
 Fate Therapeutics (FATE) | 0.94% | 0% | 37.97% | 1/2/2024 |
 Seagen Inc (SGEN) | 0.88% | 0% | 19.69% | 12/18/2023 |
 Merus (MRUS) | 0.85% | 0% | 22.06% | 1/6/2026 |
 Legend Biotech (LEGN) | 0.72% | 0% | 20.58% | 1/2/2024 |
 Incyte (INCY) | 0.71% | 0% | 17.39% | 1/12/2023 |
 BioNTech SE (BNTX) | 0.66% | 0% | 17.39% | 1/12/2023 |
 2Seventy Bio (TSVT) | 0.66% | 0% | 17.39% | 1/12/2023 |
 Option Care Health (OPCH) | 0.65% | 0% | 21.11% | 12/26/2024 |
 Rocket (RCKT) | 0.6% | 0% | 21.11% | 12/26/2024 |
 Arvinas (ARVN) | 0.59% | 0% | 21.11% | 12/26/2024 |
 Agenus (AGEN) | 0.59% | 0% | 17.39% | 1/12/2023 |
 IDEAYA (IDYA) | 0.58% | 2.39% | 23.6% | - |
 LabCorp (LH) | 0.58% | 0% | 17.39% | 1/12/2023 |
 GlaxoSmithKline (GSK) | 0.54% | 0% | 17.39% | 1/12/2023 |
 MannKind (MNKD) | 0.54% | 0% | 20.58% | 1/2/2024 |
 Cogent Biosciences (COGT) | 0.5% | 2.24% | 16.68% | - |
 Kura Oncology (KURA) | 0.47% | 2.53% | 16.09% | - |
 Sorrento (SRNE) | 0.47% | 0% | 17.39% | 1/12/2023 |
 Inovio (INO) | 0.44% | 0% | 17.39% | 1/12/2023 |
 Arcus Biosciences (RCUS) | 0.43% | 2.16% | 16.26% | - |
 NeoGenomics (NEO.US) | 0.41% | 5.03% | 8.81% | - |
 Clovis Oncology Inc (CLVSQ) | 0.4% | 0% | 16.2% | 12/22/2022 |
 Adaptive Biotechnologies (ADPT) | 0.39% | 4.83% | 8.52% | - |
 Zymeworks (ZYME) | 0.38% | 2.08% | 16.74% | - |
 Janux (JANX) | 0.37% | 0% | 21.58% | 12/29/2025 |
 Olema (OLMA) | 0.35% | 0.85% | 16.74% | - |
 Nuvalent (NUVL) | 0.34% | 0% | 11.24% | 7/17/2026 |
 Ligand (LGND) | 0.3% | 3.51% | 8.69% | - |
 Surface Oncology Inc (SURF) | 0.29% | 0% | 16.2% | 12/22/2022 |
 Invitae Corp (NVTAQ) | 0.22% | 0% | 17.39% | 1/12/2023 |
 Curis (CRIS) | 0.2% | 0% | 16.2% | 12/22/2022 |
 Novocure (NVCR) | 0.18% | 0% | 7.63% | 12/29/2025 |
 Castle Biosciences (CSTL) | 0.03% | 1.5% | 2.01% | - |
Exposure over time
Exposure by Sector
Exposure by Country
Portfolio Time Machine
Portfolio date
01
01
2026
| Instrument | Invested | Value |
|---|---|---|
| Guardant Health (GH) | 1.68% | 4.75% |
| Scholar Rock (SRRK) | 5.61% | 4.2% |
| Revolution Medicines (RVMD) | 1.73% | 3.89% |
| Bridgebio (BBIO) | 0.53% | 3.88% |
| Exact Sciences (EXAS) | 3.33% | 3.86% |
| Syndax (SNDX) | 5.26% | 3.85% |
| Olema (OLMA) | 5.06% | 3.77% |
| Eli Lilly (LLY) | 1.72% | 3.7% |
| Gilead Sciences (GILD) | 2.61% | 3.45% |
| Regeneron (REGN) | 3.95% | 3.42% |
| Cogent Biosciences (COGT) | 4.73% | 3.34% |
| Pfizer (PFE) | 5.63% | 3.31% |
| Merck (MRK) | 3.82% | 3.26% |
| AbbVie (ABBV) | 2.93% | 3.24% |
| Argenx (ARGX) | 2.09% | 3.22% |
| Johnson & Johnson (JNJ) | 3.36% | 3.22% |
| Arcellx (ACLX) | 3.82% | 3.21% |
| Merus (MRUS) | 1.93% | 3.1% |
| IDEAYA (IDYA) | 3.24% | 3.08% |
| Nuvalent (NUVL) | 4.1% | 3.08% |
| Amgen (AMGN) | 2.99% | 3.01% |
| Bristol-Myers Squibb (BMY) | 4.34% | 3% |
| AstraZeneca (AZN) | 2.82% | 2.92% |
| Arcus Biosciences (RCUS) | 3.66% | 2.91% |
| Celldex (CLDX) | 3.62% | 2.9% |
| Halozyme (HALO) | 2.65% | 2.85% |
| Illumina (ILMN) | 3.04% | 2.84% |
| BeiGene (ONC) | 3.75% | 2.82% |
| Exelixis (EXEL) | 1.82% | 2.71% |
| Zymeworks (ZYME) | 3.52% | 2.7% |
Cash & Instruments Over Time
Unlock Premium Features
Get access to this feature and many more with BullAware Pro.